ezetimibe has been researched along with Angina, Stable in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busk, M; Bøtker, HE; Dey, D; Fonte, T; Grove, EL; Hosbond, S; Iraqi, N; Jensen, JM; Leipsic, J; Mathiassen, ON; Mortensen, MB; Narula, J; Nørgaard, BL; Sand, NP; Updegrove, A | 1 |
| Arimura, T; Ike, A; Iwata, A; Kawamura, A; Miura, S; Nishikawa, H; Saku, K; Sugihara, M | 1 |
2 trial(s) available for ezetimibe and Angina, Stable
| Article | Year |
|---|---|
Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.
Topics: Angina, Stable; Atorvastatin; Ezetimibe; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Tomography, X-Ray Computed | 2022 |
Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina.
Topics: Aged; Angina, Stable; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Coronary Angiography; Ezetimibe; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Stents; Treatment Outcome | 2012 |